Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Puerto Rico

Puerto Rico Articles

Industry

BMI View: The importance of Puerto Rico as a major production hub for multinational pharmaceutical companies will slightly deteriorate due to production quality issues, drug patent... 2012-07-31


Industry

BMI View: Multinational pharmaceutical companies will open more manufacturing facilities in Puerto Rico benefiting from the low tax rate and below-average production... 2012-07-16


Industry

BMI View: Multinational pharmaceutical companies will open more manufacturing facilities in Foreign Trade Zones (FTZs) in Puerto Rico to benefit from the low tax rate and below-average... 2011-12-15


More ARTICLES

Industry

BMI Core View: Ensuring quality manufacturing standards is one of the fundamental responsibilities of pharmaceutical companies. Although costs will rise, we believe it necessary for... 2011-06-27


Industry

BMI View: The Central American healthcare sector's high growth forecast is driven by strong demographics, increased healthcare needs, longer life expectancy, increased healthcare spending... 2011-04-20


Industry

BMI View: The exacerbation of pressures to offset declining profits from several imminent patent expirations, coupled with the impact of the country's healthcare reform, means that... 2011-04-07


Industry

BMI View: We believe that a growing number of domestic drugmakers in Latin America will step up efforts to increase market presence in both developed and neighbouring emerging markets,... 2010-11-03


Industry

BMI View: Governments that implement policies to foster scientific innovation while offering lower operating costs will have a competitive advantage in attracting multinational drugmakers... 2010-10-29